‘More Work Needed’ To Restore UK Pharma Competitiveness Despite Rebate Rate Cut

 
• By Francesca Bruce
  
The new rebate rate under the UK voluntary medicines pricing scheme will drop by more than a third for 2026. (Shutterstock)

More from Pricing Debate

More from Market Access